AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
(From CBS Marketwatch (Stories))
Byline: Gerri Willis, Jen Rogers
WASHINGTON (CBS.MW) -- The Food and Drug Administration indicated Tuesday that it may want new labels on some antidepressants prescribed to children and adolescents that have been linked to increased risk of suicide.
On the second day of a panel meeting, FDA officials seemed to be leaning toward requiring the new labels, based on pediatric studies of nine antidepressants, including Eli Lilly's Prozac and Pfizer's Zoloft.
For many children, however, the benefits of taking the drugs may outweigh the risks, the agency said, asking an advisory panel of experts for input on…